Risk-stratified surveillance for individuals in the UK at high risk of developing pancreatic cancer: Outcomes from the European Registry of Hereditary Pancreatic Diseases (EUROPAC)
The risk-stratified group (FR) identifies neoplastic pancreatic lesion in individuals, regardless of PV status suggesting the key usefulness of this approach.
Authors
- Eithne Costello (ORCID: https://orcid.org/0000-0002-0104-8992)
- Phillip Hopley
- Ryan Peysner
- Kofi Oppong
- Annabelle Boughey
- Bharti Kewlani
- Zaed Hamady
- Guy Shingler
- Tejinderjit S Athwal
- Mark Taylor
- Meg Finch-Jones
- Shyam Menon
- Guruprasad P. Aithal
- William Greenhalf
- Steven Pereira
- Andrew Caleb Smith
- James Milburn
- Christopher M Halloran
- Paula Ghaneh
- Christopher Briggs
- Michael Chapman
Institutions
- Belfast Health and Social Care Trust (GB)
- University College Hospital (GB)
- Nottingham University Hospitals NHS Trust (GB)
- University of Liverpool (GB)
- University Hospitals of North Midlands NHS Trust (GB)
- Aberdeen Royal Infirmary (GB)
- University Hospitals Bristol NHS Foundation Trust (GB)
- St James's University Hospital (GB)
- Southampton General Hospital (GB)
- Morriston Hospital (GB)
- Freeman Hospital (GB)
- Derriford Hospital (GB)
- Nottingham Biomedical Research Centre (GB)
- The Royal Wolverhampton NHS Trust (GB)
- University College London (GB)
Publication Details
- Journal
- European Journal of Cancer
- Published
- 2026-02-17
- DOI
- https://doi.org/10.1016/j.ejca.2026.116592
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00